Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)
China
· Delayed Price · Currency is CNY 6.63
+0.02 (0.30%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2007 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2007 - 2019 |
| Imported Albumin | 3.63B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Imported Albumin Growth | 3.49% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Intravenous Immunoglobulin | 1.70B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Intravenous Immunoglobulin Growth | -5.91% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Self-produced Albumin | 1.49B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Self-produced Albumin Growth | 4.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Blood Products | 1.23B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Blood Products Growth | 14.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Testing Equipment and Reagents | 121.15M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Testing Equipment and Reagents Growth | -14.17% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Business | 2.85M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Business Growth | 80.85% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Albumin | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Albumin Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2007 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2007 - 2019 |
| China | 8.18B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | 2.67% |
Log In |
Log In |
Log In |
Log In | Upgrade
|